Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen Idec Inc (BIIB): Orbimed Advisors Top Stocks in Q2

Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission. For the second quarter of 2014, the hedge fund revealed 132 equity positions, worth $8.5 billion. Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets. The largest holdings of the fund are represented by Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Bristol-Myers Squibb Co (NYSE:BMY), and Biogen Idec Inc (NASDAQ:BIIB). In this article, we will discuss each of these three largest positions for the second quarter.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) is on the top position, where Orbimed Advisors currently owns 1.49 million shares. In its 13F, the fund reported ownership of 1.66 million shares of the company, with a value of more than $390 million. Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) is a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases. For the second quarter of 2014, the company reported a net income of $33.5 million for the second quarter of 2014, compared to a net loss of $13.5 million for the second quarter of 2013.

Other hedge fund holding stakes in the company include Viking Global, managed by Andreas Halvorsen, which owns 208,077 shares of Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), and Sectoral Asset Management, led by Jerome Pfund and Michael Sjostrom, which holds 73,993 shares of the company.

In Bristol-Myers Squibb Co (NYSE:BMY), Orbimed Advisors revealed holding 7.19 million shares, worth nearly $349 million. The stake represents an increase from 5.97 million shares the fund reported previously. Having a market cap of $83.5 billion, Bristol-Myers Squibb Co (NYSE:BMY) is a New-York-headquarted global biopharmaceutical company.

Last month, Bristol-Myers Squibb Co (NYSE:BMY) released its financial results for the second quarter of 2014. The company reported non-GAAP net earnings attributable to the company of $798 million, or $0.48 per share, compared to $730 million, or $0.44 per share, for the same period a year ago.

Other significant shareholders of the company include Adage Capital Management, managed by Phill Gross and Robert Atchinson, which reported holding 4.95 million shares, and Donald Chiboucis’ Columbus Circle Investors, which owns 2.89 million shares.

Biogen Idec Inc (NASDAQ:BIIB) is represented as the third largest holding, in which Orbimed Advisors disclosed owning 1.08 million shares, slightly up from 1.06 million shares the fund held earlier. The value of the position amounts to around $342 million. Biogen Idec Inc (NASDAQ:BIIB) is an independent biotechnology company engaged in development of innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Its market cap is $81.2 billion. For full-year 2014, Biogen Idec Inc (NASDAQ:BIIB) updated its financial guidance. It expects revenue growth to be approximately between 38% to 41%, and GAAP diluted EPS is expected to be between $11.26 and $11.46.

Aside from Orbimed Advisors, Columbus Circle Investors owns 1.35 million shares, and Cliff Asness’ AQR Capital Management holds 791,724 shares of the company.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!